Related Experiment Video
Updated: Dec 1, 2025
04:27
Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
5.9K
What is bronchopulmonary dysplasia and does caffeine prevent it?
1Division of Neonatology and Department of Pediatrics, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, PA, United States.
Seminars in Fetal & Neonatal Medicine
|November 10, 2020
Summary
Caffeine therapy reduces the risk of bronchopulmonary dysplasia (BPD) in premature infants by improving cardiorespiratory outcomes. However, further strategies are needed to fully prevent BPD in very low birth weight infants.
Area of Science:
- Neonatology
- Pediatric Pulmonology
- Pharmacology
Background:
- Bronchopulmonary dysplasia (BPD) is a severe complication of very premature birth.
- Lung immaturity, inflammation, and impaired repair drive BPD development.
- Current preventative strategies, including caffeine, do not eliminate BPD risk.
Purpose of the Study:
- To review the role of caffeine in preventing bronchopulmonary dysplasia.
- To explore the mechanisms by which caffeine reduces BPD risk.
- To highlight the need for novel BPD prevention methods.
Main Methods:
- Review of clinical and laboratory studies on BPD pathogenesis and caffeine therapy.
- Analysis of caffeine's cardiorespiratory and direct pulmonary effects.
- Evaluation of current preventative strategies for BPD.
Main Results:
- Caffeine initiated early significantly decreases BPD risk in very low birth weight infants.
- Benefits include reduced need for positive airway pressure and oxygen.
- Caffeine improves pulmonary mechanics and reduces PDA treatment, impacting inflammation, alveolarization, and angiogenesis.
Conclusions:
- Routine caffeine administration is recommended for most very low birth weight infants.
- Despite caffeine's benefits, BPD remains a significant challenge.
- Novel approaches are essential to further mitigate BPD risk in vulnerable infants.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
578
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
578
01:22Chronic Obstructive Pulmonary Disease
2.0K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.0K
01:17Pulmonary Cycle: Exhalation
2.7K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.7K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.3K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.3K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.9K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.9K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.9K